OFFICE OF FISCAL ANALYSIS
Legislative Office Building, Room 5200
Hartford, CT 06106 ↓ (860) 240-0200
AN ACT CONCERNING BIOLOGICAL PRODUCTS.
LCO No.: 4367
File Copy No.: 96
Senate Calendar No.: 80
OFA Fiscal Note
See Fiscal Note Details
The amendment eliminates the potential savings reductions to the state and municipal health plans of the underlying bill by removing the prohibition on mail order for interchangeable biologics. The amendment makes changes to notice requirements which do not change the fiscal impact of the underlying bill.
The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely for the purposes of information, summarization and explanation and does not represent the intent of the General Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of informational sources, including the analyst's professional knowledge. Whenever applicable, agency data is consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.